{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:41:01Z","timestamp":1794044461583,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009270","name":"DH | NIHR | Invention for Innovation","doi-asserted-by":"publisher","award":["NIHR200022"],"award-info":[{"award-number":["NIHR200022"]}],"id":[{"id":"10.13039\/501100009270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Kidney transplantation is the preferred treatment for end-stage renal disease and is limited by donor organ availability. Normothermic Machine Perfusion (NMP) might facilitate safe transplantation of marginal organs. NKP1 is a single centre, phase 1, 36-patient, three-stage cohort study investigating the safety and feasibility of up to 24\u2009hours of renal NMP prior to transplantation. 30-day graft survival (primary endpoint) was 100%. Secondary objectives were assessment of the effect of NMP on post-transplant clinical outcomes and ischaemia-reperfusion injury, identification of predictive biomarkers, and characterisation of the performance of the preservation system. Clinical outcomes were comparable to a matched control cohort with 12-month estimated glomerular filtration rate (eGFR) 46.3 vs 49.5\u2009mL\/min\/1.73m\n                    <jats:sup>2<\/jats:sup>\n                    (p\u2009=\u20090.44) despite much longer total preservation times (15.7 vs 8.9\u2009hours controls, p\u2009&lt;\u20090.0001). We saw strong correlations between biomarkers measured ex-situ and post-transplant outcomes, including graft function at one year (correlation between GST-Pi delta and 12-month eGFR,\n                    <jats:italic>R<\/jats:italic>\n                    \u2009=\u20090.54,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). Renal NMP is useful for optimising logistics and as an organ assessment technique, and has potential to expand the donor pool. Trial registration number: ISRCTN13292277.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-59829-5","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T23:08:25Z","timestamp":1747436905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Prolonged normothermic perfusion of the kidney prior to transplantation: a historically controlled, phase 1 cohort study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-4758","authenticated-orcid":false,"given":"Richard","family":"Dumbill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4837-9446","authenticated-orcid":false,"given":"Simon","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-9380","authenticated-orcid":false,"given":"John","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Voyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3946-816X","authenticated-orcid":false,"given":"Jacob","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Ellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-727X","authenticated-orcid":false,"given":"Elizabeth","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian SD","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5382-9838","authenticated-orcid":false,"given":"Tim","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-8996","authenticated-orcid":false,"given":"Jennifer","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-1815","authenticated-orcid":false,"given":"Annemarie","family":"Weissenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-665X","authenticated-orcid":false,"given":"Rutger","family":"Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8792-7818","authenticated-orcid":false,"given":"Constantin","family":"Coussios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-9685","authenticated-orcid":false,"given":"Peter","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"59829_CR1","doi-asserted-by":"crossref","unstructured":"Chaudhry, D., Chaudhry, A., Peracha, J., & Sharif, A. Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis. BMJ 376, e068769 (2022).","DOI":"10.1136\/bmj-2021-068769"},{"key":"59829_CR2","doi-asserted-by":"publisher","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","volume":"9","author":"M Wyld","year":"2012","unstructured":"Wyld, M., Morton, R. L., Hayen, A., Howard, K. & Webster, A. C. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 9, e1001307 (2012).","journal-title":"PLoS Med."},{"key":"59829_CR3","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","volume":"11","author":"M Tonelli","year":"2011","unstructured":"Tonelli, M. et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am. J. Transplant. 11, 2093\u20132109 (2011).","journal-title":"Am. J. Transplant."},{"key":"59829_CR4","doi-asserted-by":"crossref","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473\u2013485 (2024).","DOI":"10.1038\/s41581-024-00820-6"},{"key":"59829_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100585","volume":"35","author":"A Lewis","year":"2021","unstructured":"Lewis, A. et al. Organ donation in the US and Europe: the supply vs demand imbalance. Transplant. Rev. 35, 100585 (2021).","journal-title":"Transplant. Rev."},{"key":"59829_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/08968608211061126","volume":"42","author":"G Roberts","year":"2022","unstructured":"Roberts, G. et al. Current costs of dialysis modalities: a comprehensive analysis within the United Kingdom. Perit. Dial. Int. 42, 578\u2013584 (2022).","journal-title":"Perit. Dial. Int."},{"key":"59829_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10198-022-01478-2","volume":"24","author":"E Busink","year":"2023","unstructured":"Busink, E. et al. A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway. Eur. J. Health Econ. 24, 377\u2013392 (2023).","journal-title":"Eur. J. Health Econ."},{"key":"59829_CR8","doi-asserted-by":"crossref","unstructured":"Stewart, F. et al. Exploring kidney dialysis costs in the United States: a scoping review. J. Med. Econ. 12, 1\u201320 (2024).","DOI":"10.1080\/13696998.2024.2342210"},{"key":"59829_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s40472-022-00378-x","volume":"9","author":"WG Norton","year":"2022","unstructured":"Norton, W. G., Pearson, R., Devlin, J., Nicholson, M. L. & Hosgood, S. A. Normothermic machine perfusion in renal transplantation. Curr. Transpl. Rep. 9, 308\u2013317 (2022).","journal-title":"Curr. Transpl. Rep."},{"key":"59829_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/ajt.14932","volume":"19","author":"A Weissenbacher","year":"2019","unstructured":"Weissenbacher, A. et al. Twenty-four\u2013hour normothermic perfusion of discarded human kidneys with urine recirculation. Am. J. Transplant. 19, 178\u2013192, https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/ajt.14932 (2019).","journal-title":"Am. J. Transplant."},{"key":"59829_CR11","doi-asserted-by":"crossref","unstructured":"Arykbaeva, A. S. et al. Red blood cells as oxygen carrier during normothermic machine perfusion of kidney grafts: friend or foe? Am. J. Transplant. 24, 1172\u20131179 (2024).","DOI":"10.1016\/j.ajt.2024.01.002"},{"key":"59829_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-019-0181-0","volume":"15","author":"K Van Avondt","year":"2019","unstructured":"Van Avondt, K., Nur, E. & Zeerleder, S. Mechanisms of haemolysis-induced kidney injury. Nat. Rev. Nephrol. 15, 671\u2013692 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"59829_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrneph.2010.124","volume":"6","author":"I Mimura","year":"2010","unstructured":"Mimura, I. & Nangaku, M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat. Rev. Nephrol. 6, 667\u2013678 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"59829_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/ALN.0000000000001461","volume":"126","author":"L Lannemyr","year":"2017","unstructured":"Lannemyr, L. et al. Effects of cardiopulmonary bypass on renal perfusion, filtration, and oxygenation in patients undergoing cardiac surgery. Anesthesiology 126, 205\u2013213 (2017).","journal-title":"Anesthesiology"},{"key":"59829_CR15","doi-asserted-by":"crossref","unstructured":"Hosgood, S. A. et al. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial. Nat. Med. 29, 1511\u20131519 (2023).","DOI":"10.1038\/s41591-023-02376-7"},{"key":"59829_CR16","doi-asserted-by":"crossref","unstructured":"Rijkse, E. et al. Safety and feasibility of 2\u2009h of normothermic machine perfusion of donor kidneys in the Eurotransplant Senior Program. BJS Open. 5, zraa024 (2021).","DOI":"10.1093\/bjsopen\/zraa024"},{"key":"59829_CR17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/ajt.12179","volume":"13","author":"SA Hosgood","year":"2013","unstructured":"Hosgood, S. A. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am. J. Transplant. 13, 1246\u20131252 (2013).","journal-title":"Am. J. Transplant."},{"key":"59829_CR18","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1097\/TP.0000000000004098","volume":"106","author":"LI Mazilescu","year":"2022","unstructured":"Mazilescu, L. I. et al. Normothermic ex vivo kidney perfusion for human kidney transplantation: first North American Results. Transplantation 106, 1852\u20131859 (2022).","journal-title":"Transplantation"},{"key":"59829_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/bjs.10733","volume":"105","author":"SA Hosgood","year":"2018","unstructured":"Hosgood, S. A., Thompson, E., Moore, T., Wilson, C. H. & Nicholson, M. L. Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors. Br. J. Surg. 105, 388\u2013394 (2018).","journal-title":"Br. J. Surg."},{"key":"59829_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/ajt.14059","volume":"17","author":"JM Kaths","year":"2017","unstructured":"Kaths, J. M. et al. Continuous normothermic Ex vivo kidney perfusion is superior to brief normothermic perfusion following static cold storage in donation after circulatory death pig kidney transplantation. Am. J. Transplant. 17, 957\u2013969 (2017).","journal-title":"Am. J. Transplant."},{"key":"59829_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/ajt.16929","volume":"22","author":"ER Thompson","year":"2022","unstructured":"Thompson, E. R. et al. MicroRNA antagonist therapy during normothermic machine perfusion of donor kidneys. Am. J. Transplant. 22, 1088\u20131100 (2022).","journal-title":"Am. J. Transplant."},{"key":"59829_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1089\/scd.2020.0024","volume":"29","author":"MBF Pool","year":"2020","unstructured":"Pool, M. B. F. et al. Treating ischemically damaged porcine kidneys with human bone marrow- and adipose tissue-derived mesenchymal stromal cells during ex vivo normothermic machine perfusion. Stem Cells Dev. 29, 1320\u20131330 (2020).","journal-title":"Stem Cells Dev."},{"key":"59829_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ajt.16148","volume":"21","author":"JR DiRito","year":"2021","unstructured":"DiRito, J. R. et al. Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys. Am. J. Transplant. 21, 161\u2013173 (2021).","journal-title":"Am. J. Transplant."},{"key":"59829_CR24","doi-asserted-by":"crossref","unstructured":"Tietjen, G. T. et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. Sci. Transl. Med. 9, eaam6764 (2017).","DOI":"10.1126\/scitranslmed.aam6764"},{"key":"59829_CR25","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/ajt.16307","volume":"21","author":"TR Elliott","year":"2021","unstructured":"Elliott, T. R., Nicholson, M. L. & Hosgood, S. A. Normothermic kidney perfusion: an overview of protocols and strategies. Am. J. Transplant. 21, 1382\u20131390 (2021).","journal-title":"Am. J. Transplant."},{"key":"59829_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/bjs\/znac293","volume":"110","author":"S MacMillan","year":"2023","unstructured":"MacMillan, S., Hosgood, S. A. & Nicholson, M. L. Enzymatic blood group conversion of human kidneys during ex vivo normothermic machine perfusion. Br. J. Surg. 110, 133\u2013137 (2023).","journal-title":"Br. J. Surg."},{"key":"59829_CR27","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1097\/TXD.0000000000000888","volume":"5","author":"H Peters-Sengers","year":"2019","unstructured":"Peters-Sengers, H. et al. Impact of cold ischemia time on outcomes of deceased donor kidney transplantation: an analysis of a national registry. Transpl. Direct 5, e448 (2019).","journal-title":"Transpl. Direct"},{"key":"59829_CR28","doi-asserted-by":"crossref","unstructured":"Dumbill, R. et al. Transplant and recipient factors in prediction of kidney transplant outcomes: a UK-Wide paired analysis. J. Clin. Med. 11, 2222 (2022).","DOI":"10.3390\/jcm11082222"},{"key":"59829_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100570","volume":"5","author":"EL Lum","year":"2023","unstructured":"Lum, E. L., Homkrailas, P., Abdalla, B., Danovitch, G. M. & Bunnapradist, S. Cold ischemia time, kidney donor profile index, and kidney transplant outcomes: a cohort study. Kidney Med. 5, 100570 (2023).","journal-title":"Kidney Med."},{"key":"59829_CR30","unstructured":"Kidney Advisory Group on behalf of NHSBT. POL186\/11 \u2013 Kidney Transplantation: Deceased Donor Organ Allocation [Internet]. 2021 [cited 2024 Apr 15]. Available from: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/22127\/pol186.pdf."},{"key":"59829_CR31","unstructured":"Mazilescu, L. I. et al. Prolonged normothermic ex vivo kidney perfusion is superior to cold nonoxygenated and oxygenated machine perfusion for the preservation of DCD porcine Kidney Grafts. Transplant Direct [Internet]. 2021 [cited 2022 Sep 27]; Available from: https:\/\/journals.lww.com\/transplantationdirect\/Fulltext\/2021\/10000\/Prolonged_Normothermic_Ex_Vivo_Kidney_Perfusion_Is.6.aspx."},{"key":"59829_CR32","doi-asserted-by":"crossref","unstructured":"Urbanellis, P. et al. Normothermic Ex vivo kidney perfusion improves early DCD graft function compared with hypothermic machine perfusion and static cold storage. Transplantation 2020. 947\u2013955. Available from: https:\/\/journals.lww.com\/transplantjournal\/Fulltext\/2020\/05000\/Normothermic_Ex_Vivo_Kidney_Perfusion_Improves.16.aspx (2020).","DOI":"10.1097\/TP.0000000000003066"},{"key":"59829_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","volume":"62","author":"S Hariharan","year":"2002","unstructured":"Hariharan, S. et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 62, 311\u2013318 (2002).","journal-title":"Kidney Int."},{"key":"59829_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/tri.13593","volume":"33","author":"F Guzzi","year":"2020","unstructured":"Guzzi, F., Knight, S. R., Ploeg, R. J. & Hunter, J. P. A systematic review to identify whether perfusate biomarkers produced during hypothermic machine perfusion can predict graft outcomes in kidney transplantation. Transpl. Int. 33, 590\u2013602 (2020).","journal-title":"Transpl. Int."},{"key":"59829_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/ajt.12635","volume":"14","author":"IE Hall","year":"2014","unstructured":"Hall, I. E. et al. Glutathione S-transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function. Am. J. Transplant. 14, 886\u2013896 (2014).","journal-title":"Am. J. Transplant."},{"key":"59829_CR36","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/TP.0b013e3181f5c40c","volume":"90","author":"C Moers","year":"2010","unstructured":"Moers, C. et al. The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation 90, 966\u2013973 (2010).","journal-title":"Transplantation"},{"key":"59829_CR37","doi-asserted-by":"crossref","unstructured":"Lo Faro, M. L. et al. Kidney tissue proteome profiles in short versus long duration of delayed graft function - a pilot study in donation after circulatory death donors. Kidney Int. Rep. 9, 1473\u20131483 (2024).","DOI":"10.1016\/j.ekir.2024.02.012"},{"key":"59829_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/ajt.14491","volume":"18","author":"JM Kaths","year":"2018","unstructured":"Kaths, J. M. et al. Normothermic ex vivo kidney perfusion for graft quality assessment prior to transplantation. Am. J. Transplant. 18, 580\u2013589, https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/ajt.14491 (2018).","journal-title":"Am. J. Transplant."},{"key":"59829_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/TP.0000000000002299","volume":"103","author":"SK Kabagambe","year":"2019","unstructured":"Kabagambe, S. K. et al. Combined Ex vivo hypothermic and normothermic perfusion for assessment of high-risk deceased donor human kidneys for transplantation. Transplantation 103, 392\u2013400 (2019).","journal-title":"Transplantation"},{"key":"59829_CR40","doi-asserted-by":"publisher","first-page":"F352","DOI":"10.1152\/ajprenal.00253.2021","volume":"321","author":"L Bankir","year":"2021","unstructured":"Bankir, L. Could an intrarenal Cori cycle participate in the urinary concentrating mechanism? Am. J. Physiol. Ren. Physiol. 321, F352\u2013F353 (2021).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"59829_CR41","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan, J. M., Morgan, R. D., Knight, S. R., & Morris, P. J. Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. British J. Surg. 100, 991\u20131001 (2013).","DOI":"10.1002\/bjs.9169"},{"key":"59829_CR42","doi-asserted-by":"crossref","unstructured":"Tingle, S. J. et al. Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: a meta-analysis. Clin. Transplant. 34, e13814 (2020).","DOI":"10.1111\/ctr.13814"},{"key":"59829_CR43","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(20)32411-9","volume":"396","author":"I Jochmans","year":"2020","unstructured":"Jochmans, I. et al. Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial. Lancet. 396, 1653, https:\/\/www.eurotransplant.org (2020).","journal-title":"Lancet."},{"key":"59829_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jamasurg.2021.0949","volume":"156","author":"P Husen","year":"2021","unstructured":"Husen, P. et al. Oxygenated end-hypothermic machine perfusion in expanded criteria donor kidney transplant: a randomized clinical trial. JAMA Surg. 156, 517\u2013525 (2021).","journal-title":"JAMA Surg."},{"key":"59829_CR45","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1097\/TP.0000000000001504","volume":"101","author":"SA Hosgood","year":"2017","unstructured":"Hosgood, S. A. & Nicholson, M. L. An assessment of urinary biomarkers in a series of declined human kidneys measured during ex vivo normothermic kidney perfusion. Transplantation 101, 2120\u20132125 (2017).","journal-title":"Transplantation"},{"key":"59829_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep26335","volume":"6","author":"KH Shu","year":"2016","unstructured":"Shu, K. H. et al. Urinary \u03c0-glutathione S-transferase predicts advanced acute kidney injury following cardiovascular surgery. Sci. Rep. 6, 26335 (2016).","journal-title":"Sci. Rep."},{"key":"59829_CR47","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1681\/ASN.2015040345","volume":"27","author":"PP Reese","year":"2016","unstructured":"Reese, P. P. et al. Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. J. Am. Soc. Nephrol. 27, 1534\u20131543 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"59829_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2369-14-271","volume":"14","author":"B Redal-Baigorri","year":"2013","unstructured":"Redal-Baigorri, B., Rasmussen, K. & Heaf, J. G. The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study. BMC Nephrol. 14, 271 (2013).","journal-title":"BMC Nephrol."},{"key":"59829_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"R Mosteller","year":"1987","unstructured":"Mosteller, R. Simplified calculation of body-surface area. N. Engl. J. Med. 317, 1098\u20131098 (1987).","journal-title":"N. Engl. J. Med."},{"key":"59829_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood.2023022385","volume":"143","author":"R Dumbill","year":"2024","unstructured":"Dumbill, R. et al. Impaired O2 unloading from stored blood results in diffusion-limited O2 release at tissues: evidence from human kidneys. Blood 143, 721\u2013733 (2024).","journal-title":"Blood"},{"key":"59829_CR51","doi-asserted-by":"publisher","first-page":"i969","DOI":"10.1136\/bmj.i969","volume":"352","author":"N Pearce","year":"2016","unstructured":"Pearce, N. Analysis of matched case-control studies. BMJ 352, i969 (2016).","journal-title":"BMJ"},{"key":"59829_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious, S. A. Sample size of 12 per group rule of thumb for a pilot study. Pharm. Stat. 4, 287\u2013291 (2005).","journal-title":"Pharm. Stat."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59829-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T23:08:32Z","timestamp":1747436912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59829"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59829-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4687115\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Peter Friend is a founder and is the Chief Medical Officer of OrganOx Ltd Constantin Coussios is a founder and is the Chief Technical Officer of OrganOx Ltd R.D., S.K. and J.F. have received consultancy fees from OrganOx Ltd for work outside the scope of this trial. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4584"}}